Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

The move comes at a time when Omicron and its sub-variants have remained the dominant strains in circulation for close to two years now. Most of the vaccines available and administered in......

India may ease clinical trial norms for coronavirus vaccine

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be......